These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37493027)

  • 1. β-Blocker Therapy After Myocardial Infarction: A Little Goes a Long Way.
    Abbott JD; Goldberger JJ
    J Am Heart Assoc; 2023 Aug; 12(15):e030867. PubMed ID: 37493027
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous β-blockers in primary percutaneous coronary intervention: new hope for an old therapy.
    Ndrepepa G; Kastrati A
    Circulation; 2013 Oct; 128(14):1487-9. PubMed ID: 24002793
    [No Abstract]   [Full Text] [Related]  

  • 3. Relationship Between β-Blocker Therapy at Discharge and Clinical Outcomes in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    Li C; Sun Y; Shen X; Yu T; Li Q; Ruan G; Zhang L; Huang Q; Zhuang H; Huang J; Ni L; Wang L; Jiang J; Wang Y; Wang DW
    J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27852588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacotherapy: β-Blocker therapy before PCI for STEMI reduces infarct size.
    Lim GB
    Nat Rev Cardiol; 2013 Dec; 10(12):681. PubMed ID: 24042218
    [No Abstract]   [Full Text] [Related]  

  • 5. Should We Be Using Upstream Beta-Blocker Therapy for Acute Myocardial Infarction?
    Giannakopoulos G; Noble S
    Curr Cardiol Rep; 2021 May; 23(6):66. PubMed ID: 33961118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of β-blockers on left ventricular remodeling in patients with preserved ejection fraction after acute myocardial infarction.
    Horiuchi Y; Tanimoto S; Aoki J; Nakajima H; Hara K; Tanabe K
    Int J Cardiol; 2016 Oct; 221():765-9. PubMed ID: 27428318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefit of Vasodilating β-Blockers in Patients With Acute Myocardial Infarction After Percutaneous Coronary Intervention: Nationwide Multicenter Cohort Study.
    Chung J; Han JK; Kim YJ; Kim CJ; Ahn Y; Chan Cho M; Chae SC; Chae IH; Chae JK; Seong IW; Yang HM; Park KW; Kang HJ; Koo BK; Jeong MH; Kim HS;
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29066446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-blocker use in patients after percutaneous coronary interventions: one size fits all? Worse outcomes in patients without myocardial infarction or heart failure.
    Ozasa N; Morimoto T; Bao B; Furukawa Y; Nakagawa Y; Kadota K; Iwabuchi M; Shizuta S; Shiomi H; Tazaki J; Natsuaki M; Kimura T;
    Int J Cardiol; 2013 Sep; 168(2):774-9. PubMed ID: 23127614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial.
    Ibanez B; Macaya C; Sánchez-Brunete V; Pizarro G; Fernández-Friera L; Mateos A; Fernández-Ortiz A; García-Ruiz JM; García-Álvarez A; Iñiguez A; Jiménez-Borreguero J; López-Romero P; Fernández-Jiménez R; Goicolea J; Ruiz-Mateos B; Bastante T; Arias M; Iglesias-Vázquez JA; Rodriguez MD; Escalera N; Acebal C; Cabrera JA; Valenciano J; Pérez de Prado A; Fernández-Campos MJ; Casado I; García-Rubira JC; García-Prieto J; Sanz-Rosa D; Cuellas C; Hernández-Antolín R; Albarrán A; Fernández-Vázquez F; de la Torre-Hernández JM; Pocock S; Sanz G; Fuster V
    Circulation; 2013 Oct; 128(14):1495-503. PubMed ID: 24002794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term impact of β-blocker in elderly patients without myocardial infarction after percutaneous coronary intervention.
    Fukase T; Dohi T; Koike T; Yasuda H; Takeuchi M; Takahashi N; Chikata Y; Endo H; Doi S; Nishiyama H; Okai I; Iwata H; Okazaki S; Miyauchi K; Daida H; Minamino T
    ESC Heart Fail; 2022 Feb; 9(1):545-554. PubMed ID: 34811932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Outcomes with or without Beta-Blocker Therapy After Acute Myocardial Infarction in Patients Without Heart Failure or Left Ventricular Systolic Dysfunction (from the Acute Coronary Syndromes Israeli Survey [ACSIS]).
    El Nasasra A; Beigel R; Klempfner R; Alnsasra H; Matetzky S; Iakobishvili Z; Rubinshtein R; Halabi M; Blatt A; Zahger D
    Am J Cardiol; 2021 Mar; 143():1-6. PubMed ID: 33359228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term efficacy of vasodilating β-blocker in patients with acute myocardial infarction: nationwide multicenter prospective registry.
    Chung J; Han JK; Yang HM; Park KW; Kang HJ; Koo BK; Jeong MH; Kim HS;
    Korean J Intern Med; 2021 Mar; 36(Suppl 1):S62-S71. PubMed ID: 32615654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of beta blockade therapy on long-term mortality after ST-segment elevation acute myocardial infarction in the percutaneous coronary intervention era.
    Nakatani D; Sakata Y; Suna S; Usami M; Matsumoto S; Shimizu M; Hara M; Uematsu M; Fukunami M; Hamasaki T; Sato H; Hori M; Komuro I;
    Am J Cardiol; 2013 Feb; 111(4):457-64. PubMed ID: 23228922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to letter regarding article, "effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial".
    Ibanez B; Macaya C; Sánchez-Brunete V; Pizarro G; Fernández-Friera L; Mateos A; Fernández-Ortiz A; García-Ruiz JM; García-Álvarez A; Iñiguez A; Jiménez-Borreguero J; López-Romero P; Fernández-Jiménez R; Goicolea J; Ruiz-Mateos B; Bastante T; Arias M; Iglesias-Vázquez JA; Rodriguez MD; Escalera N; Acebal C; Cabrera JA; Valenciano J; de Prado AP; Fernández-Campos MJ; Casado I; García-Rubira JC; García-Prieto J; Sanz-Rosa D; Cuellas C; Hernández-Antolín R; Albarrán A; Fernández-Vázquez F; de la Torre-Hernández JM; Pocock S; Sanz G; Fuster V
    Circulation; 2014 Jul; 130(3):e19-20. PubMed ID: 25024129
    [No Abstract]   [Full Text] [Related]  

  • 15. Lack of effect of oral beta-blocker therapy at discharge on long-term clinical outcomes of ST-segment elevation acute myocardial infarction after primary percutaneous coronary intervention.
    Ozasa N; Kimura T; Morimoto T; Hou H; Tamura T; Shizuta S; Nakagawa Y; Furukawa Y; Hayashi Y; Nakao K; Matsuzaki M; Nobuyoshi M; Mitsudo K;
    Am J Cardiol; 2010 Nov; 106(9):1225-33. PubMed ID: 21029817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter by Argulian and Messerli regarding article, "effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial".
    Argulian E; Messerli FH
    Circulation; 2014 Jul; 130(3):e18. PubMed ID: 25024128
    [No Abstract]   [Full Text] [Related]  

  • 17. [The impact of pre-primary percutaneous coronary intervention β blocker use on the no-reflow phenomenon in patients with acute myocardial infarction].
    Wang J; Chen Y; Wang C; Zhu X
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Oct; 42(10):822-6. PubMed ID: 25547444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing oral beta-blocker therapy after percutaneous coronary intervention for ST-segment elevation myocardial infarction: the role of observational data.
    Granger CB; Rao MP
    JACC Cardiovasc Interv; 2014 Jun; 7(6):602-3. PubMed ID: 24947718
    [No Abstract]   [Full Text] [Related]  

  • 19. Beta-blockers for suspected or diagnosed acute myocardial infarction.
    Safi S; Sethi NJ; Nielsen EE; Feinberg J; Jakobsen JC; Gluud C
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD012484. PubMed ID: 31845756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-Blocker Use after Discharge in Patients with Acute Myocardial Infarction in the Contemporary Reperfusion Era.
    Hu M; Hu S; Gao X; Yang Y
    Medicina (Kaunas); 2022 Aug; 58(9):. PubMed ID: 36143854
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.